Sanaria Revenue and Competitors
Estimated Revenue & Valuation
- Sanaria's estimated annual revenue is currently $11.2M per year.
- Sanaria's estimated revenue per employee is $155,000
Employee Data
- Sanaria has 72 Employees.
- Sanaria grew their employee count by -1% last year.
Sanaria's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | VP International Projects and Strategy | Reveal Email/Phone |
3 | Associate Director, Manufacturing Operations | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
5 | Senior Director | Reveal Email/Phone |
6 | Director, Mosquito Production | Reveal Email/Phone |
7 | Senior Director Quality | Reveal Email/Phone |
8 | Director Intellectual Property | Reveal Email/Phone |
9 | Chief Legal Officer | Reveal Email/Phone |
10 | Managing Director, Vaccine extraction, Immunology and Model Systems | Reveal Email/Phone |
Sanaria Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is Sanaria?
Sanaria Inc. was founded in 2003. The company's mission is to develop and commercialize a malaria sporozoite vaccine against Plasmodium falciparum, the parasite responsible for more than 95 percent of malaria-associated severe illness and death world-wide, and the malaria parasite for which there is the most significant drug resistance. Sanaria plans to begin the first human trials of its Malaria Vaccine in 2009.
keywords:N/AN/A
Total Funding
72
Number of Employees
$11.2M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sanaria News
PNG's Sanaria Butler finished first in the long jump, triple jump and 400-meter dash. Nederland's Ke'Asia Hall finished second in the long...
Sanaria Inc; Nobelpharma Co; Sumaya Biotech; GenVec. Mexico Malaria Vaccines Market Breakdown by Type: Pre-Erythrocytic Vaccine; Erythrocytic...
GlaxoSmithKline plc; Sanaria Inc; Nobelpharma Co; Sumaya Biotech; GenVec. Malaria Vaccines Market Breakdown by Type: Pre-Erythrocytic Vaccine...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.5M | 72 | 6% | N/A |
#2 | $10.7M | 72 | -8% | N/A |
#3 | $9.4M | 72 | 9% | N/A |
#4 | $9.5M | 73 | 1% | N/A |
#5 | $7.5M | 73 | 9% | N/A |